Patent 8404641 was granted and assigned to Elixir Medical Corporation on March, 2013 by the United States Patent and Trademark Office.
A method of inhibiting cell migration or treating an inflammatory condition, comprising administering a compound disclosed herein to the subject, is provided. The compound can be administered systemically, locally, or a combination thereof. For example, the compound can be locally delivered from a temporary device or an implant, such as a vascular prosthesis.